Skip to main content
2025 Neural Interfaces Meeting Main banner
Unparalleled proactive care. Optimizing the SCS experience. Website: neuro.biotronik.com

Chad Andresen, MS

Chief Business Officer
LunOSA
Somerville, Massachusetts, United States

Chad brings a wealth of expertise amassed over a remarkable 15-year career, showcasing his diverse roles as a Medical-Device executive, sales VP, marketer, inventor, engineer, and disruptive leader.

At Curonix/Stimwave, Chad made significant strides in healthcare innovation by designing micro-sized neurostimulator implants for the treatment of chronic pain, OAB, and migraines. During his tenure, the company achieved remarkable growth, reaching an impressive $50 million in annual revenue. Under Chad's leadership, Curonix successfully implanted over 10,000 patients with its groundbreaking products, evolving from a co-founder trio to a workforce of over 150 employees. His contributions extended beyond the commercial realm, with Chad co-authoring over 50 patents that have been issued globally, while an additional 40 applications are currently in progress.

Since 2021, Chad began expanding his scope in MedTech by acting as an executive for burgeoning medical device technologies, spanning from ortho to pain to sleep to lung diseases. After starting & cofounding numerous companies, Chad has successfully led 5 companies through their Seed/Series-A fundraising rounds accumulating a total of $22M. Chad now leads business development at LunOSA, a clinical-stage startup raising Series-B. LunOSA is developing the NERVE-NET, a self-expanding stimulator to treat Obstructive Sleep Apnea amidst a $10B Market opportunity.

Presentation(s):